← All trials
NCT01408381
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2011
- Primary completion
- Jun 30, 2015
- Completion date
- Jun 30, 2015
- First posted
- Aug 3, 2011
- Last posted
- Mar 16, 2016
- Enrollment
- 38
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Andalusian Initiative for Advanced TherapiesLead sponsor
- Andalusian Initiative in Advanced TherapiesCollaborator
- Universidad de CordobaStudy chair
- Universidad de CordobaOfficial
- University Hospital Virgen de las NievesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.